Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)
Clinical trial NCT07371533 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07371533
- Sponsor
- Shanxi Bethune Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2027-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.